Tirzepatide has emerged as a groundbreaking therapy for type 2 diabetes, offering promising effects. However, the expense of this innovative drug and its availability have become key concerns for patients and healthcare providers. While tirzepatide has been authorized by regulatory agencies, its high-priced nature presents a significant obstacle t